Numoda Corporation
The Curtis Center
601 Walnut Street, 9th Floor
Philadelphia
Pennsylvania
19106-3323
United States
Tel: 215-238-8881
Fax: 215-238-9995
Website: http://www.numoda.com/
11 articles about Numoda Corporation
-
Proteonomix, Inc. (PROT) Retains Numoda Corporation to Provide Clinical Trial Services for Phase 1 Trial With UMK-121 in End-Stage Liver Disease
9/12/2012
-
Proteonomix, Inc. (PROT) Engages Numoda Corporation for Clinical Trial Services
9/4/2012
-
Cleveland Clinic and Numoda Corporation are Collaborating to Accelerate the Process by Which Research Discoveries are Moved From the Laboratory to Patient Care
7/18/2012
-
IntelliCell BioSciences Announces Powerful Collaboration with Numoda Corporation
12/13/2011
-
Pro-Pharmaceuticals, Inc. Collaborates with Numoda Corporation to Manage Phase III Clinical Trial to Increase Speed-to-Market for DAVANAT(R)
9/13/2010
-
Provectus Pharmaceuticals Inc. to Use Numoda Corporation's TruPoints System to Facilitate Transactions with Potential Licensing Partners for PH-10
7/27/2010
-
Advaxis, Inc. Engages the Numoda Corporation to Oversee Phase II Clinical Trials of ADXS11-001
6/23/2009
-
DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
3/25/2009
-
Columbia Laboratories, Inc. Raises $750,000 through Sale of Common Stock
1/7/2009
-
DOR BioPharma, Inc. Announces Collaboration With Numoda for the Execution of Confirmatory, Phase 3 Clinical Trial of orBec(R)
6/30/2008
-
Neuro-Hitech, Inc. Announces Agreement with Numoda to Progress Development of Huperzine A in Alzheimer's Disease
3/10/2008